Endotronics Inc decision discontinue development health care product reorganize Chapter 11 establish adequate allowance uncollectible receivables expect establish reserve total 11 mln dlrs March 31 quarter. The company plan seek buyer health care technology include proprietary right Hepatitis B Vaccine technology related LAK cell cancer immunotherapy. Reuter 